Granahan Investment Management - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 54 filers reported holding XENON PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,071,666
-11.4%
236,290
-0.2%
0.29%
+2.9%
Q2 2023$9,114,991
-7.7%
236,753
-14.2%
0.28%
-7.0%
Q1 2023$9,878,469
-22.7%
276,012
-14.9%
0.30%
-23.0%
Q4 2022$12,785,178
+18.1%
324,250
+8.1%
0.39%
+10.8%
Q3 2022$10,825,000
+25.0%
299,855
+5.3%
0.35%
+19.3%
Q2 2022$8,663,000
+7.9%
284,772
+8.4%
0.30%
+48.7%
Q1 2022$8,031,000
+18.3%
262,705
+20.9%
0.20%
+42.1%
Q4 2021$6,788,000
+429.9%
217,301
+159.1%
0.14%
+483.3%
Q3 2021$1,281,000
-17.4%
83,854
+0.7%
0.02%
-17.2%
Q2 2021$1,550,000
+4.2%
83,249
+0.2%
0.03%
-9.4%
Q1 2021$1,487,000
-36.9%
83,088
-45.8%
0.03%
-39.6%
Q4 2020$2,358,000
+34.2%
153,321
-3.4%
0.05%
-11.7%
Q3 2020$1,757,000
+26.2%
158,704
+43.0%
0.06%
+20.0%
Q2 2020$1,392,000
+10.6%
110,9990.0%0.05%
-26.5%
Q1 2020$1,259,000
-10.1%
110,999
+3.9%
0.07%
+6.2%
Q4 2019$1,401,000
+46.1%
106,839
+0.4%
0.06%
+20.8%
Q3 2019$959,000
-1.0%
106,459
+8.3%
0.05%
+10.4%
Q2 2019$969,000
-12.2%
98,259
-9.6%
0.05%
-18.6%
Q1 2019$1,104,000108,6790.06%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders